Discover Aesthetic Doctors Limited 13486271 false 2024-12-30 2025-12-29 2025-12-29 The principal activity of the company is the provision of aesthetic medicine. Digita Accounts Production Advanced 6.30.9574.0 true 13486271 2024-12-30 2025-12-29 13486271 2025-12-29 13486271 bus:OrdinaryShareClass1 2025-12-29 13486271 core:CurrentFinancialInstruments 2025-12-29 13486271 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-29 13486271 core:FurnitureFittingsToolsEquipment 2025-12-29 13486271 core:LandBuildings 2025-12-29 13486271 core:MotorVehicles 2025-12-29 13486271 core:OtherRelatedParties 2025-12-29 13486271 core:ParentEntities 2025-12-29 13486271 bus:SmallEntities 2024-12-30 2025-12-29 13486271 bus:AuditExemptWithAccountantsReport 2024-12-30 2025-12-29 13486271 bus:FilletedAccounts 2024-12-30 2025-12-29 13486271 bus:SmallCompaniesRegimeForAccounts 2024-12-30 2025-12-29 13486271 bus:RegisteredOffice 2024-12-30 2025-12-29 13486271 bus:Director1 2024-12-30 2025-12-29 13486271 bus:OrdinaryShareClass1 2024-12-30 2025-12-29 13486271 bus:PrivateLimitedCompanyLtd 2024-12-30 2025-12-29 13486271 core:FurnitureFittingsToolsEquipment 2024-12-30 2025-12-29 13486271 core:LandBuildings 2024-12-30 2025-12-29 13486271 core:LeaseholdImprovements 2024-12-30 2025-12-29 13486271 core:MotorVehicles 2024-12-30 2025-12-29 13486271 core:OfficeEquipment 2024-12-30 2025-12-29 13486271 core:OtherRelatedParties 2024-12-30 2025-12-29 13486271 core:ParentEntities 2024-12-30 2025-12-29 13486271 countries:England 2024-12-30 2025-12-29 13486271 2024-12-29 13486271 core:FurnitureFittingsToolsEquipment 2024-12-29 13486271 core:LandBuildings 2024-12-29 13486271 core:MotorVehicles 2024-12-29 13486271 core:OtherRelatedParties 2024-12-29 13486271 core:ParentEntities 2024-12-29 13486271 2023-12-30 2024-12-29 13486271 2024-12-29 13486271 bus:OrdinaryShareClass1 2024-12-29 13486271 core:CurrentFinancialInstruments 2024-12-29 13486271 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-29 13486271 core:FurnitureFittingsToolsEquipment 2024-12-29 13486271 core:LandBuildings 2024-12-29 13486271 core:MotorVehicles 2024-12-29 13486271 core:OtherRelatedParties 2024-12-29 13486271 core:ParentEntities 2024-12-29 13486271 core:OtherRelatedParties 2023-12-30 2024-12-29 13486271 core:ParentEntities 2023-12-30 2024-12-29 13486271 2023-12-29 13486271 core:OtherRelatedParties 2023-12-29 13486271 core:ParentEntities 2023-12-29 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13486271

Discover Aesthetic Doctors Limited

Unaudited Filleted Financial Statements

for the Year Ended 29 December 2025

 

Discover Aesthetic Doctors Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 6

 

Discover Aesthetic Doctors Limited

(Registration number: 13486271)
Balance Sheet as at 29 December 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

90,951

108,552

Current assets

 

Stocks

7,174

7,175

Debtors

5

896

728

 

8,070

7,903

Creditors: Amounts falling due within one year

6

(238,566)

(201,731)

Net current liabilities

 

(230,496)

(193,828)

Net liabilities

 

(139,545)

(85,276)

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

(139,645)

(85,376)

Shareholders' deficit

 

(139,545)

(85,276)

For the financial year ending 29 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 September 2026 and signed on its behalf by:
 

.........................................
Mrs G E Montero Garcia
Director

 

Discover Aesthetic Doctors Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Crow Wood Leisure
Royle Lane
Burnley
Lancashire
BB12 0RT

These financial statements were authorised for issue by the Board on 25 September 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Discover Aesthetic Doctors Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 December 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Improvements to leasehold property

Straight line over the period of the lease

Office equipment

10% per annum straight line basis

Motor vehicles

25% per annum reducing balance basis

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Discover Aesthetic Doctors Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 December 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 9 (2024 - 8).

4

Tangible assets

Improvements to leasehold properties
£

Office equipment
£

Motor vehicles
 £

Total
£

Cost

At 30 December 2024

2,398

125,349

48,033

175,780

At 29 December 2025

2,398

125,349

48,033

175,780

Depreciation

At 30 December 2024

2,397

37,062

27,769

67,228

Charge for the year

-

12,535

5,066

17,601

At 29 December 2025

2,397

49,597

32,835

84,829

Net book value

At 29 December 2025

1

75,752

15,198

90,951

At 29 December 2024

1

88,287

20,264

108,552

5

Debtors

2025
£

2024
£

Other debtors

896

728

896

728

 

Discover Aesthetic Doctors Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 December 2025

6

Creditors

Note

2025
£

2024
£

Due within one year

 

Trade creditors

 

3,978

-

Amounts owed to group undertakings and undertakings in which the company has a participating interest

8

233,291

199,656

Taxation and social security

 

337

228

Accruals and deferred income

 

960

960

Other creditors

 

-

887

 

238,566

201,731

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

       

8

Related party transactions

Summary of transactions with parent

Discover Laser Group Limited

Summary of transactions with other related parties

Discover Laser Limited

Loans from related parties

2025

Parent
£

Other related parties
£

Total
£

At start of period

1,914

197,742

199,656

Advanced

-

33,634

33,634

At end of period

1,914

231,376

233,290

 

Discover Aesthetic Doctors Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 December 2025

2024

Parent
£

Other related parties
£

Total
£

At start of period

1,914

152,710

154,624

Advanced

-

45,032

45,032

At end of period

1,914

197,742

199,656